Co-release of endogenous ATP and [3H]noradrenaline from rat hypothalamic slices: Origin and modulation by α2-adrenoceptors

Neuroscience

Volumn 82, Issue 2, 1997, Pages 511-520

  Sperlagh B ^a   Sershen, H ^b   Lajtha, A ^b   Vizi, E S ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

6 hydroxydopamine; ATP; Co transmission; Hypothalamus; Noradrenaline; Release

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM IODIDE; 14ALPHA HYDROXY 7,8 METHYLENEDIOXYALLOBERBANE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; ADENOSINE TRIPHOSPHATE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; LUCIFERASE; LUCIFERIN; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; NORADRENALIN; OXIDOPAMINE; RECEPTOR SUBTYPE; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; BRAIN STEM; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; DORSAL NORADRENERGIC BUNDLE; ELECTROSTIMULATION; HYPOTHALAMUS; MALE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; STEREOTAXIS;

EID: 0342547310     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00306-0     Document Type: Article

References (66)

1. Albe-Fessard, D., Stutinsky, F. and Libouban, S. (1966) Atlas stéréotaxique du diencephale du rat blanc. Editions du CNRS, Paris.
2. 2A-adrenergic receptor-like immunoreactivity. Brain Res. 650:1994;181-204.
3. 2x ATP receptors in rat brain. Br. J. Pharmac. 115:1995;302-306.
4. 2x7) receptors regulate intracellular calcium and purine release. NeuroReport. 7:1996;2533-2537.
5. Bloom F. E. (1971) Fine structural changes in rat brain after intracisternal injection of 6-hydroxydopamine. In 6-Hydroxydopamine and Catecholamine Neurons (eds Maimfors T. and Thoenen H.), pp. 135. Elsevier, Amsterdam.
6. 3H]α,β-methylene ATP binding sites in rat brain and spinal cord. NeuroReport. 5:1994;1601-1604.
7. 2-Adrenoceptor-mediated autoinhibition of sympathetic transmitter release in guinea-pig vas deferens studied by intracellular and focal extracellular recording of junction potentials and currents. Naunyn-Schmiedeberg's Arch. Pharmac. 342:1990;45-52.
8. Buller K. M., Khanna S., Sibbald J. R., Day T. A. Central noradrenergic neurons signal via ATP to elicit vasopressin responses to haemorrhage. Neuroscience. 73:1996;637-642.
9. Burnstock G. Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem. Int. 17:1990;357-368.
10. 2B-adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J. Pharmac. exp. Ther. 245:1988;600-602.
11. 2-adrenergic receptors. Fedn Am. Soc. exp. Biol. J. 6:1992;832-839.
12. Chen Z. P., Levy A., Lightman S. L. Activation of specific ATP receptors induces a rapid increase in intracellular calcium ions in rat hypothalamic neurons. Brain Res. 641:1994;249-256.
13. Chen Z. P., Levy A., Lightman S. L. Nucleotides as extracellular signalling molecules. J. Neuroendocrinol. 7:1995;83-96.
14. 2x6 receptors and distribution and properties of an extended family of ATP-gated ion channels. Neuroscience. 16:1996;2495-2507.
15. Day T. A., Renaud L., Sibbald J. R. Excitation of supraoptic vasopressin cells by stimulation of the A1 noradrenaline cell group: failure to demonstrate role for established adrenergic and amino acid receptors. Brain Res. 516:1990;91-98.
16. Day T. A., Sibbald J. R., Khanna S. ATP mediates an excitatory noradrenergic neuron input to supraoptic vasopressin cells. Brain Res. 607:1993;341-344.
17. 2-adrenoceptor-mediated modulation in guinea-pig vas deferens. Naunyn-Schmiedeberg's Arch. Pharmac. 348:1994;358-366.
18. Edwards F. A., Gibb A. J., Colquhoun D. ATP receptor-mediated synaptic currents in the central nervous system. Nature. 359:1992;144-147.
19. 3H-adenine labelled hypothalamic synaptosomes. Acta physiol. scand. 106:1979;97-107.
20. Gaillet S., Alonso G., Le Borgne R., Barbanel G., Malaval F., Assenmacher I., Szafarczyk A. Effects of discrete lesions in the ventral noradrenergic ascending bundle on the corticotropic stress response depend on the site of the lesion and on the plasma levels of adrenal steroids. Neuroendocrinology. 58:1993;408-419.
21. Gaillet S., Lachuer J., Malaval F., Assenmacher I., Szafarcyk A. The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors. Expl Brain Res. 87:1991;173-180.
22. Gartside S. E., Suaud-Chagny M. F., Tappaz M. Evidence that activation of the hypothalamo-pituitary-adrenal axis by electrical stimulation of the noradrenegic A1 group is not mediated by noradrenaline. Neuroendocrinology. 62:1995;2-12.
23. Geffen L. B., Livett B. G. Synaptic vesicles in sympathetic neurons. Physiol. Rev. 51:1996;98-157.
24. Gieroba Z. J., Shapoval L. N., Blessing W. W. Inhibition of the A1 area prevents haemorrhage-induced secretion of vasopressin in rats. Brain Res. 657:1994;330-332.
25. 3H-NE from hypothalamus. Biochem. Pharmac. 21:1972;1829-1838.
26. 3H]noradrenaline and ATP from nerve varicosities isolated from the myenteric plexus of the guinea-pig. Can. J. Physiol. Pharmac. 66:1988;369-375.
27. 2-purinoceptor-mediated depolarization of rat supraoptic neurosecretory cells in vitro. J. Physiol., Lond. 489:1995;805-811.
28. 2 purinoceptors and pyrimidinoceptors of catecholamine-producing cells and immunocytes. In P2-Purinoceptors: Localization, Function and Transduction Mechanisms, Ciba Foundation Symposium 198 (eds Chadwick D. J. and Goode J. A.), pp. 110-129. John Wiley, Chichester.
29. Illes P., Nieber K., Nörenberg W. Electrophysiological effects of ATP on brain neurons. J. auton. Pharmac. 16:1996;407-411.
30. 2D subtype. Molec. Pharmac. 45:1994;509-516.
31. Kiss J. P., Sershen H., Lajtha A., Vizi E. S. Inhibition of neuronal nitric oxide synthase potentiates the dimethylphenylpiperazinium-evoked carrier mediated release of noradrenaline from rat hippocampal slices. Neurosci. Lett. 215:1996;115-118.
32. 2-adrenoceptors modulating hippocampal norepinephrine release in rat. Brain Res. 674:1992;238-244.
33. 2-adrenergic receptor subtype-specific antibodies. Molec. Pharmac. 43:1992;444-450.
34. Mori M., Tsushima H., Matsuda T. Antidiuretic effects of purinoceptor agonists injected into the hypothalamic paraventricular nucleus of water loaded ethanol-anaesthetized rats. Neuropharmacology. 31:1992;585-592.
35. Okuda H., Shioda S., Nakai Y., Nakayama H., Okamoto M., Nakashima T. Immunocytochemical localization of nicotinic acetylcholine receptor in rat hypothalamus. Brain Res. 625:1993;145-151.
36. Pacak K., Palkovits M., Kopin I. J., Goldstein D. S. Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary - adrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Front. Neuroendocrinol. 16:1995;89-150.
37. Palkovits M. Catecholamines in the hypothalamus: an anatomical review. Neuroendocrinology. 33:1981;123-128.
38. Paton D. M. Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria. Br. J. Pharmac. 49:1973;614-627.
39. Piccolino M., Pignatelli A. Calcium-independent synaptic transmission: fact or artifact? Trends Neurosci. 16:1996;415-419.
40. Potter P., White T. D. Release of adenosine 5′-triphosphate from synaptosomes from different regions of rat brain. Neuroscience. 5:1980;1351-1356.
41. Potter P. E., White T. D. Lack of effect of 6-hydroxydopamine pretreatment on depolarization-induced release of ATP from rat brain synaptosomes. Eur. J. Pharmac. 80:1982;143-147.
42. Querioz G., Gebicke-Haerter P. J., Schobert A., Starke K. and von Kugelgen I. (1997) Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience (in press).
43. Sargent P. B. The diversity of neuronal nicotinic acetylcholine receptors. A. Rev. Neurosci. 16:1993;403-443.
44. 2A subtype. J. Neurochem. 63:1994;1077-1085.
45. Sawchenko P. E., Swanson L. W. Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses. Science. 214:1981;685-687.
46. 2-adrenergic receptor subtype gene expression in rat brain. Molec. Brain Res. 21:1994;133-149.
47. Sedaa K. O., Bjur R. A., Shinozuka K., Westfall D. P. Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta. J. Pharmac. exp. Ther. 252:1989;1060-1067.
48. Sershen H., Balia A., Lajtha A., Vizi E S. Characterization of nicotinic receptors involved in the release of norepinephrine from hippocampus. Neuroscience. 77:1996;121-130.
49. Sharp B. M., Nicol S., Cummings S., Seybold V. Distribution of nicotinic binding sites with respect to CRF and neurophysin immunoreactive perikarya within the rat hypothalamus. Brain Res. 422:1987;361-366.
50. 2-adrenoceptor-mediated modulation? Neuroscience. 51:1992;203-209.
51. Sperlágh B., Kittel A., Lajtha A., Vizi E. S. ATP acts as fast neurotransmitter in rat habenula: neurochemical and enzyme cytochemical evidence. Neuroscience. 66:1995;915-920.
52. Sperlágh B., Tóth E., Lajtha A., Vizi E. S. Effect of (-)nicotine on the endogenous ATP release from rat striatum and cerebral cortex. Int. J. of Purine Pyrimidine Res. 3:1992;105.
53. Sperlágh B., Vizi E. S. Neuronal synthesis, storage and release of ATP. Semin. Neurosci. 8:1996;175-186.
54. 2A in the rabbit. Naunyn-Schmiedeberg's Arch. Pharmac. 348:1993;35-45.
55. 14C-ATP. Eur. J. Pharmac. 158:1988;69-77.
56. Vizi E. S., Harsing L. G., Zimanyi I., Gaal G. Release and turnover of noradrenaline in isolated median eminence: lack of negative feedback modulation. Neuroscience. 16:1985;907-916.
57. Vizi E. S., Sershen H., Balla A., Mike Á., Windisch K., Jurányi Zs., Lajtha A. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors. Ann. N. Y. Acad. Sci. 757:1995;84-99.
58. Vizi E. S., Somogyi G. T., Harsing L. G., Zimanyi I. External Ca-independent release of norepinephrine by sympathomimetics and its role in negative feedback modulation. Proc. natn. Acad. Sci. U.S.A. 82:1985;8775-8780.
59. 1-adrenoceptor agonists. Neurochem. Res. 11:1986;71-84.
60. Vizi E. S., Sperlágh B., Baranyi M. Evidence that ATP, released from the postsynaptic site by noradrenaline, is involved in mechanical responses of guinea-pig vas deferens: cascade transmission. Neuroscience. 50:1992;455-465.
61. von Kugelgen I., Starke K. Release of noradrenaline and ATP by electrical stimulation and nicotine in guinea-pig vas deferens. Naunyn-Schmiedeberg's Arch. Pharmac. 344:1991;419-429.
62. von Kugelgen I., Starke K. Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends pharmac. Sci. 12:1991;319-324.
63. von Kugelgen I. Modulation of neural ATP release through presynaptic receptors. Semin. Neurosci. 8:1996;247-257.
64. Whittaker V. P. The synaptic vesicle. Handbook Neurochem. 7:1982;41-69.
65. 2B adrenoceptor subtypes. Eur. J. Pharmac. 168:1989;381-386.
66. Zimmermann H. Signalling via ATP in the nervous system. Trends Neurosci. 17:1994;420-426.